Making pathology data available for research across organizations requires more than secure technology. It requires clear governance, legal and ethical frameworks, and transparency about how Bigpicture itself is managed. Bigpicture connects these elements to support responsible research while protecting data subjects, data contributors and users.
How Bigpicture is governed
Bigpicture is currently governed as a European public-private research initiative, with structures that support strategic decision-making, project oversight and independent advice. The project is jointly led by Jeroen van der Laak and Katrien Grünberg of Radboud University Medical Center, together with Julie Boisclair of Novartis and Anna-Lena Frisk of Johnson & Johnson Innovative Medicine.
Its governance structure enables consortium-level decision-making with specialist advisory and coordination bodies:
General Assembly
The main decision-making body of the consortium, bringing together representatives of the Bigpicture partners.
Managing Board
Responsible for overseeing the management, coordination and progress of the project.
Multi-stakeholder Advisory Board
Provides external perspectives and expertise from relevant stakeholder groups, including regulation, clinical practice, industry, academia and patient representation.
Ethics Advisory Board
Provides independent expertise and oversight on ethical and legal aspects of Bigpicture, including data sharing and data protection.
Node Coordination Board
Coordinates the network involved in pathology data contributions and supports the quality and diversity of data entering Bigpicture.